Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia G Kaklamani

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Oncology (Williston Park, N.Y.)|January 5, 2018
Developments in Breast Cancer 2017-2018: New Drugs, New Drug Classes-and the Prospect of More to ComeVirginia G Kaklamani
The Oncologist|June 4, 2016
Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast CancerVirginia G Kaklamani
Expert Review of Anticancer Therapy|July 24, 2004
Role of TGF-beta in cancer and the potential for therapy and preventionVirginia G Kaklamani, Boris Pasche
Cancer Treatment and Research|January 20, 2018
Multi-gene Panel Testing in Breast Cancer ManagementChristos Fountzilas, Virginia G Kaklamani
Current Treatment Options in Oncology|February 4, 2006
Gene expression in breast cancerVirginia G Kaklamani, William J Gradishar
International Journal of Breast Cancer|February 2, 2012
Metabolic syndrome and triple-negative breast cancer: a new paradigmAndrew A Davis, Virginia G Kaklamani
Expert Review of Anticancer Therapy|April 15, 2006
Role of efaproxiral in metastatic brain tumorsRyan H Engel, Virginia G Kaklamani
The Oncologist|March 19, 2017
Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast CancerVirginia G Kaklamani, William J Gradishar
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Is the Preoperative Setting an Appropriate Platform for Drug Approval in Breast Cancer?Virginia G Kaklamani, William J Gradishar
Cancer Investigation|October 6, 2005
Adjuvant therapy of breast cancerVirginia G Kaklamani, William J Gradishar
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Oncology (Williston Park, N.Y.)|January 5, 2018
Developments in Breast Cancer 2017-2018: New Drugs, New Drug Classes-and the Prospect of More to ComeVirginia G Kaklamani
The Oncologist|June 4, 2016
Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast CancerVirginia G Kaklamani
Expert Review of Anticancer Therapy|July 24, 2004
Role of TGF-beta in cancer and the potential for therapy and preventionVirginia G Kaklamani, Boris Pasche
Cancer Treatment and Research|January 20, 2018
Multi-gene Panel Testing in Breast Cancer ManagementChristos Fountzilas, Virginia G Kaklamani
Current Treatment Options in Oncology|February 4, 2006
Gene expression in breast cancerVirginia G Kaklamani, William J Gradishar
International Journal of Breast Cancer|February 2, 2012
Metabolic syndrome and triple-negative breast cancer: a new paradigmAndrew A Davis, Virginia G Kaklamani
Expert Review of Anticancer Therapy|April 15, 2006
Role of efaproxiral in metastatic brain tumorsRyan H Engel, Virginia G Kaklamani
The Oncologist|March 19, 2017
Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast CancerVirginia G Kaklamani, William J Gradishar
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Is the Preoperative Setting an Appropriate Platform for Drug Approval in Breast Cancer?Virginia G Kaklamani, William J Gradishar
Cancer Investigation|October 6, 2005
Adjuvant therapy of breast cancerVirginia G Kaklamani, William J Gradishar
Pageof 7